Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-17-012361

Options or other derivatives

  • Chief Scientific Officer acquired 84,267 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts M Scot Chief Scientific Officer 2017-05-04 Grant or award · Stock Option (option to buy) +55,120 55,120 D: show line 1 in the form
Roberts M Scot Chief Scientific Officer 2017-05-04 Grant or award · Stock Option (option to buy) +8,956 8,956 D: show line 2 in the form
Roberts M Scot Chief Scientific Officer 2017-05-04 Grant or award · Stock Option (option to buy) +8,956 8,956 D: show line 3 in the form
Roberts M Scot Chief Scientific Officer 2017-05-04 Grant or award · Stock Option (option to buy) +11,235 11,235 D: show line 4 in the form
Loading xslF345X03/doc4.xml…